A case of Duchenne muscular dystrophy recovered from prolonged ischemic kidney injury which emerged with a normal creatinine level
- PMID: 38436872
- PMCID: PMC11444038
- DOI: 10.1007/s13730-024-00858-2
A case of Duchenne muscular dystrophy recovered from prolonged ischemic kidney injury which emerged with a normal creatinine level
Abstract
Duchenne muscular dystrophy (DMD) is an inherited disease characterized by progressive degeneration of the skeletal muscles. Renal dysfunction in patients with DMD has recently become more apparent as life expectancy has increased owing to advances in respiratory devices and heart failure therapies. A 23-year-old man with DMD who required nasal tube feeding was referred to our hospital with a 4-month history of renal dysfunction and anemia. The patient's serum creatinine (sCr) level was within the normal range (0.84 mg/dL), but his serum cystatin C level and estimated glomerular filtration rate calculated by cystatin C (5.90 mg/L and 7.5 mL/min/1.73 m2, respectively) indicated severe renal impairment. A urinalysis revealed elevated levels of protein and tubular markers. The patient's hemoglobin and erythropoietin levels indicated renal anemia. Hypotension, a collapsed inferior vena cava, and a poor tube feeding episode suggested that the kidney injury was due to renal ischemia, which progressed to tubulointerstitial kidney injury, an intrinsic kidney injury. The angiotensin-converting enzyme inhibitors and beta-blockers were discontinued, and extracellular fluid was infused. Thereafter, the patient's renal function recovered. Subsequently, the patient's urinary findings and anemia improved. Although advances in cardioprotective agents are expected to improve the prognosis of patients with DMD, it is important to consider that the number of patients with kidney injury due to renal ischemia may increase and that it is difficult to evaluate renal function using sCr level in patients with DMD because of decreased skeletal muscle mass.
Keywords: Cystatin C; Dehydration; Duchenne muscular dystrophy; Kidney injury.
© 2024. The Author(s), under exclusive licence to Japanese Society of Nephrology.
Conflict of interest statement
The authors have declared that no conflict of interest exists.
Figures




Similar articles
-
Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C.Neuromuscul Disord. 2016 Oct;26(10):637-642. doi: 10.1016/j.nmd.2016.07.010. Epub 2016 Jul 27. Neuromuscul Disord. 2016. PMID: 27542440
-
Duchenne Muscular Dystrophy with Extreme Emaciation and a Discrepancy between Cystatin C-based eGFR and Inulin Clearance.Intern Med. 2025 Aug 15;64(16):2462-2465. doi: 10.2169/internalmedicine.4920-24. Epub 2025 Feb 8. Intern Med. 2025. PMID: 39924228
-
Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy.Muscle Nerve. 2009 Sep;40(3):438-42. doi: 10.1002/mus.21420. Muscle Nerve. 2009. PMID: 19623638 Free PMC article.
-
Biomarkers of renal function, which and when?Clin Chim Acta. 2015 Jan 1;438:350-7. doi: 10.1016/j.cca.2014.08.039. Epub 2014 Sep 3. Clin Chim Acta. 2015. PMID: 25195004 Review.
-
The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice.Eur J Intern Med. 2017 Apr;39:1-8. doi: 10.1016/j.ejim.2016.12.001. Epub 2016 Dec 21. Eur J Intern Med. 2017. PMID: 28011057 Review.
References
-
- Ishikawa Y, Miura T, Aoyagi T, Ogata H, Hamada S, Minami R. Duchenne muscular dystrophy: survival by cardio-respiratory interventions. Neuromuscul Disord. 2011;21:47–51. - PubMed
-
- Matsumura T, Saito T, Fujimura H, Shinno S, Sakoda S. A longitudinal cause-of-death analysis of patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku. 2011;51:743–50. - PubMed
-
- Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S, GFR CDtJEfE. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61:197–203. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources